Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 4
2006 6
2007 15
2008 50
2009 52
2010 40
2011 58
2012 103
2013 100
2014 105
2015 103
2016 138
2017 144
2018 152
2019 139
2020 74
2021 73
2022 63
2023 59
2024 53
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,307 results

Results by year

Filters applied: . Clear all
Page 1
Synergies, partnership outcomes, and lessons learned: a qualitative evaluation of cancer center-coalition engagement.
Villalobos A, Lipman PD, Beebe-Dimmer J, Borrayo EA, Briant KJ, Bruegl A, Dee C, Chavez S, Drake B, Johnson SS, Kikuchi K, Leeman J, Lowery J, Mendoza JA, Parker M, Purvis L, Wells Sittig K, Thompson HS, Wangen M, Wheeler SB. Villalobos A, et al. JNCI Cancer Spectr. 2025 Apr 30;9(3):pkaf038. doi: 10.1093/jncics/pkaf038. JNCI Cancer Spectr. 2025. PMID: 40205614 Free PMC article.
Cancer-related health behaviors during the COVID 19 pandemic in geographically diverse samples across the US.
Greteman BB, Cole A, Charlton ME, Shannon J, Kepka D, Paskett ED, Borrayo EA, Studts JL, Thompson HS, Scarinci I, Hinton LC, Chrischilles EA, Garcia-Auguste CJ, Christini K, Aker H, Plascak JJ, Harper FWK, Baskin ML, Bae S, Pandya V, Kim YI, Faseru B, Befort C, Kuo H, Dignan M, Canedo J, Champion V, Drake BF, Davis KL, Friedman DL, Elsaid MI, Mama SK, Cohn WF. Greteman BB, et al. BMC Cancer. 2025 Jan 9;25(1):50. doi: 10.1186/s12885-024-13373-5. BMC Cancer. 2025. PMID: 39789488 Free PMC article.
Autophagy and cancer therapy.
Pimentel JM, Zhou JY, Wu GS. Pimentel JM, et al. Cancer Lett. 2024 Nov 28;605:217285. doi: 10.1016/j.canlet.2024.217285. Epub 2024 Oct 10. Cancer Lett. 2024. PMID: 39395780 Review.
Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T.
Brown MC, D'Anniballe VM, Boczkowski D, Kandadi H, Sheikh N, Kornahrens W Jr, Heath EI, Thakur A, Chen W, Lum L, Cackowski FC, Boerner J, Gunn MD, Armstrong AJ, Nair SK. Brown MC, et al. Cancer Res Commun. 2024 Oct 1;4(10):2724-2733. doi: 10.1158/2767-9764.CRC-24-0439. Cancer Res Commun. 2024. PMID: 39320053 Free PMC article.
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.
Heath E, Dyson G, Ribeiro JR, Xiu J, Poorman K, Mamdani H, Al-Hallak MN, Shields AF, Elayoubi JA, Winer IS, Cackowski FC, Puckrein GA, Lopes GL, Jones N, Hauke RJ, Kareff SA, Radovich M, Sledge GW, Spetzler DB, Vidal GA, Marshall JL. Heath E, et al. Cancer Res Commun. 2024 Oct 1;4(10):2598-2609. doi: 10.1158/2767-9764.CRC-24-0321. Cancer Res Commun. 2024. PMID: 39172022 Free PMC article.
Evaluation of the Immune Response within the Tumor Microenvironment in African American and Non-Hispanic White Patients with Non-Small Cell Lung Cancer.
Trendowski MR, Watza D, Lusk CM, Lonardo F, Ratliff V, Wenzlaff AS, Mamdani H, Neslund-Dudas C, Boerner JL, Schwartz AG, Gibson HM. Trendowski MR, et al. Cancer Epidemiol Biomarkers Prev. 2024 Sep 3;33(9):1220-1228. doi: 10.1158/1055-9965.EPI-24-0333. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38953893 Free PMC article.
Hypothalamic sex-specific metabolic shift by canagliflozin during aging.
Jayarathne HSM, Sullivan R, Stilgenbauer L, Debarba LK, Kuchumov A, Koshko L, Scofield S, Liu W, Ginsburg BC, Miller RA, Sadagurski M. Jayarathne HSM, et al. Geroscience. 2024 Oct;46(5):4479-4493. doi: 10.1007/s11357-024-01214-z. Epub 2024 May 27. Geroscience. 2024. PMID: 38801647 Free PMC article.
The Janus kinase 1 is critical for pancreatic cancer initiation and progression.
Shrestha H, Rädler PD, Dennaoui R, Wicker MN, Rajbhandari N, Sun Y, Peck AR, Vistisen K, Triplett AA, Beydoun R, Sterneck E, Saur D, Rui H, Wagner KU. Shrestha H, et al. Cell Rep. 2024 May 28;43(5):114202. doi: 10.1016/j.celrep.2024.114202. Epub 2024 May 10. Cell Rep. 2024. PMID: 38733583 Free PMC article.
Protein kinase A is a functional component of focal adhesions.
Kang M, Senatore AJ, Naughton H, McTigue M, Beltman RJ, Herppich AA, Pflum MKH, Howe AK. Kang M, et al. J Biol Chem. 2024 May;300(5):107234. doi: 10.1016/j.jbc.2024.107234. Epub 2024 Mar 27. J Biol Chem. 2024. PMID: 38552737 Free PMC article.
Dual activity of Minnelide chemosensitize basal/triple negative breast cancer stem cells and reprograms immunosuppressive tumor microenvironment.
Korkaya H, Koksalar Alkan F, Caglayan A, Alkan H, Benson E, Gunduz Y, Sensoy O, Durdagi S, Zarbaliyev E, Dyson G, Assad H, Shull A, Chadli A, Shi H, Ozturk G. Korkaya H, et al. Res Sq [Preprint]. 2024 Feb 22:rs.3.rs-3959342. doi: 10.21203/rs.3.rs-3959342/v1. Res Sq. 2024. Update in: Sci Rep. 2024 Sep 28;14(1):22487. doi: 10.1038/s41598-024-72989-6. PMID: 38464167 Free PMC article. Updated. Preprint.
The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia.
Su Y, Carter JL, Li X, Fukuda Y, Gray A, Lynch J, Edwards H, Ma J, Schreiner P, Polin L, Kushner J, Dzinic SH, Buck SA, Pruett-Miller SM, Hege-Hurrish K, Robinson C, Qiao X, Liu S, Wu S, Wang G, Li J, Allen JE, Prabhu VV, Schimmer AD, Joshi D, Kalhor-Monfared S, Watson IDG, Marcellus R, Isaac MB, Al-Awar R, Taub JW, Lin H, Schuetz JD, Ge Y. Su Y, et al. Cancer Res. 2024 Apr 1;84(7):1084-1100. doi: 10.1158/0008-5472.CAN-23-2659. Cancer Res. 2024. PMID: 38266099 Free PMC article.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.
Hurrish KH, Su Y, Patel S, Ramage CL, Zhao J, Temby BR, Carter JL, Edwards H, Buck SA, Wiley SE, Hüttemann M, Polin L, Kushner J, Dzinic SH, White K, Bao X, Li J, Yang J, Boerner J, Hou Z, Al-Atrash G, Konoplev SN, Busquets J, Tiziani S, Matherly LH, Taub JW, Konopleva M, Ge Y, Baran N. Hurrish KH, et al. Biochem Pharmacol. 2024 Feb;220:115981. doi: 10.1016/j.bcp.2023.115981. Epub 2023 Dec 10. Biochem Pharmacol. 2024. PMID: 38081370 Free PMC article.
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells.
Yankelevich M, Thakur A, Modak S, Chu R, Taub J, Martin A, Schalk DL, Schienshang A, Whitaker S, Rea K, Lee DW, Liu Q, Shields A, Cheung NK, Lum LG. Yankelevich M, et al. Res Sq [Preprint]. 2023 Nov 9:rs.3.rs-3570311. doi: 10.21203/rs.3.rs-3570311/v1. Res Sq. 2023. Update in: J Immunother Cancer. 2024 Mar 21;12(3):e008744. doi: 10.1136/jitc-2023-008744. PMID: 37986911 Free PMC article. Updated. Preprint.
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.
Khan HY, Nagasaka M, Aboukameel A, Alkhalili O, Uddin MH, Bannoura SF, Mzannar Y, Azar I, Beal EW, Tobon ME, Kim SH, Beydoun R, Baloglu E, Senapedis W, El-Rayes BF, Philip PA, Mohammad RM, Shields AF, Al Hallak MN, Azmi AS. Khan HY, et al. Mol Cancer Ther. 2023 Dec 1;22(12):1422-1433. doi: 10.1158/1535-7163.MCT-23-0251. Mol Cancer Ther. 2023. PMID: 37703579 Free PMC article.
Multitargeted 6-Substituted Thieno[2,3-d]pyrimidines as Folate Receptor-Selective Anticancer Agents that Inhibit Cytosolic and Mitochondrial One-Carbon Metabolism.
Tong N, Wong-Roushar J, Wallace-Povirk A, Shah Y, Nyman MC, Katinas JM, Schneider M, O'Connor C, Bao X, Kim S, Li J, Hou Z, Matherly LH, Dann CE 3rd, Gangjee A. Tong N, et al. ACS Pharmacol Transl Sci. 2023 Apr 26;6(5):748-770. doi: 10.1021/acsptsci.3c00020. eCollection 2023 May 12. ACS Pharmacol Transl Sci. 2023. PMID: 37200803 Free PMC article.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis.
Hurrish KH, Su Y, Patel S, Ramage CL, Carter JL, Edwards H, Buck SA, Wiley SE, Hüttemann M, Polin L, Kushner J, Dzinic SH, White K, Bao X, Li J, Yang J, Boerner J, Hou Z, Al-Atrash G, Konoplev SN, Busquets J, Tiziani S, Matherly LH, Taub JW, Konopleva M, Ge Y, Baran N. Hurrish KH, et al. Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2843025. doi: 10.21203/rs.3.rs-2843025/v1. Res Sq. 2023. Update in: Biochem Pharmacol. 2024 Feb;220:115981. doi: 10.1016/j.bcp.2023.115981. PMID: 37162954 Free PMC article. Updated. Preprint.
Quality of life in endometrial cancer survivors by grade of disease.
Banning K, Fucinari J, Fielder A, Ruterbusch JJ, Beebe-Dimmer JL, Schwartz AG, Wallbillich JJ, Cote ML. Banning K, et al. Cancer Med. 2023 Jun;12(12):13675-13686. doi: 10.1002/cam4.5987. Epub 2023 May 6. Cancer Med. 2023. PMID: 37148545 Free PMC article.
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study.
Choueiri TK, McDermott DF, Merchan J, Bauer TM, Figlin R, Heath EI, Michaelson MD, Arrowsmith E, D'Souza A, Zhao S, Roy A, Perini R, Vickery D, Tykodi SS. Choueiri TK, et al. Lancet Oncol. 2023 May;24(5):553-562. doi: 10.1016/S1470-2045(23)00097-9. Epub 2023 Mar 31. Lancet Oncol. 2023. PMID: 37011650 Clinical Trial.
1,307 results